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Résumé en
anglais
Mutations in the oligophrenin 1 gene (OPHN1) have been identified in patients with
X-linked intellectual disability (XLID) associated with cerebellar hypoplasia and
ventriculomegaly, suggesting it could be a recognizable syndromic intellectual
disability (ID). Affected individuals share additional clinical features including
speech delay, seizures, strabismus, behavioral difficulties, and slight facial
dysmorphism. OPHN1 is located in Xq12 and encodes a Rho-GTPase-activating
protein involved in the regulation of the G-protein cycle. Rho protein members play
an important role in dendritic growth and in plasticity of excitatory synapses. Here
we report on 17 individuals from four unrelated families affected by mild to severe
intellectual disability due to OPHN1 mutations without cerebellar anomaly on brain
MRI. We describe clinical, genetic and neuroimaging data of affected patients.
Among the identified OPHN1 mutations, we report for the first time a missense
mutation occurring in a mosaic state. We discuss the intrafamilial clinical variability
of the disease and compare our patients with those previously reported. We
emphasize the power of next generation techniques (X-exome sequencing, whole-
exome sequencing and targeted multi-gene panel) to expand the phenotypic and
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